Richard Bujaroski

Richard Bujaroski is a Research Fellow in Medicinal Chemistry at Monash University, actively contributing to interdisciplinary research in drug discovery and molecular pharmacology. His work spans tuberculosis, antifungal agents, ion channel modulation, and kinase-related neurological disorders.

Research Interests: His expertise lies in medicinal and organic chemistry, with a strong focus on drug discovery for infectious and neurological diseases. He investigates bioisosteres for tuberculosis, amiloride analogs for antifungal and ion channel applications, and kinase targets in cerebral cavernous malformations. His research integrates synthetic chemistry with biological evaluation.

The recent publications (2022–2024) reflect a trend toward developing targeted inhibitors for specific biological pathways, including dual-target antibacterials, ASIC inhibitors for neurological conditions, and P2X7 receptor antagonists for inflammation. His work is highly collaborative, often involving teams from pharmacology, microbiology, and neuroscience disciplines.

Scientific Contributions: While no formal awards are listed, his research has been published in reputable journals such as Cell Chemical Biology, Frontiers in Cellular and Infection Microbiology, and Biomolecules, with several papers receiving citations and attention on academic platforms.

Advising and Grants: There is no public information on students advised or grants led by Dr. Bujaroski. However, his active publication record suggests strong involvement in funded research projects, likely under senior investigators like M. J. Kelso. His role as a Research Fellow indicates he is a key contributor to collaborative grants in medicinal chemistry and drug development.

Labs and Teams: He is part of a research network at Monash University focused on medicinal chemistry and drug discovery, particularly within the group led by Professor Martin J. Kelso. His collaborations extend to experts in microbiology, electrophysiology, and molecular biology, indicating integration into a multidisciplinary research environment.